2018
DOI: 10.1111/cbdd.13174
|View full text |Cite
|
Sign up to set email alerts
|

A novel class of human 15‐LOX‐1 inhibitors based on 3‐hydroxycoumarin

Abstract: Inflammations, sensitivities, and some cancers in mammals are intimately linked to the activity of lipo-oxygenase enzymes. Owing to the importance of these enzymes, mechanistic studies, product analysis, and synthesis of inhibitors have expanded. In this study, a series of hydroxycoumarins, methoxy-3-hydroxy coumarins, and 7-alkoxy-3-hydroxy coumarins were synthesized and evaluated as potential inhibitors of human 15-LOX-1. Among the synthetic coumarins, 7-methoxy-3-hydroxycoumarin derivative demonstrated pote… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…The desired allyl and diallyl phenols were synthesized by Claisen rearrangement on the related allyoxyphenols. After preparation and full characterization of the monoallyl compounds, The LOX inhibitory potency was studied against 15‐hLOX‐1 using the modified oxidative coupling of 3‐methyl‐2‐benzothiazolinone (MBTH) with 3‐(dimethylamino) benzoic acid (DMAB), which was reported by Alavi et al (Alavi et al, 2018). After investigating the enzyme inhibition results of the monoallyl compounds, the best inhibitors were selected for converting to diallyl analogs.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The desired allyl and diallyl phenols were synthesized by Claisen rearrangement on the related allyoxyphenols. After preparation and full characterization of the monoallyl compounds, The LOX inhibitory potency was studied against 15‐hLOX‐1 using the modified oxidative coupling of 3‐methyl‐2‐benzothiazolinone (MBTH) with 3‐(dimethylamino) benzoic acid (DMAB), which was reported by Alavi et al (Alavi et al, 2018). After investigating the enzyme inhibition results of the monoallyl compounds, the best inhibitors were selected for converting to diallyl analogs.…”
Section: Resultsmentioning
confidence: 99%
“…The immediate products of fatty acid oxidation by LOX have been shown to be associated with acute and chronic diseases such as stroke, myocardial infarction, asthma, cancer, inflammation and many other diseases and pathological states. Due to the importance of LOX as therapeutic target, there is currently much interest for the discovery and synthesis of novel and potent LOX inhibitors (Alavi, Sadeghian, Seyedi, Salimi, & Eshghi, 2018; Mousavian et al, 2020; Sadeghian, Seyedi, Saberi, Arghiania, & Riazi, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Because of their importance as therapeutic targets, work has been devoted to the discovery of pathways for the synthesis of new and potent inhibitors of this lipo-oxygenase. Several natural and synthetic derivatives of hydroxycoumarins have been reported as lipo-oxygenase inhibitors [63][64][65][66][67]. Most of them inhibit lipo-oxygenase pathways using the redox mechanism with their hydroxyl groups.…”
Section: Human 15-lox-1 Inhibitors Based On 3-hydroxycoumarinmentioning
confidence: 99%
“…Most of them inhibit lipo-oxygenase pathways using the redox mechanism with their hydroxyl groups. Alavi et al [66] analysed the lipo-oxygenase inhibitory power of monohydroxycoumarins against human 15-LOX-1 enzymes and their radical scavenging activity was comparatively observed. Among the coumarins mentioned, the 3-hydroxy derivative was the potent lipo-oxygenase inhibitor with an IC50 value of 9.5 µm.…”
Section: Human 15-lox-1 Inhibitors Based On 3-hydroxycoumarinmentioning
confidence: 99%
“…Several natural and synthetic derivatives of hydroxycoumarins have been reported as inhibitors of the lipoxygenase pathways (Alavi et al, 2018; Kontogiorgis & Hadjipavlou‐Litina, 2005). Most of them inhibit the lipoxygenase activity using redox mechanism via their hydroxyl groups.…”
Section: Introductionmentioning
confidence: 99%